Pleural cytokines MIF and MIP-3α as novel biomarkers for complicated parapneumonic effusions and empyema
Abstract Patients with complicated parapneumonic effusion (CPPE)/empyema have high morbidity and mortality, particularly when adequate management is delayed. We aimed to investigate novel dysregulated cytokines that can be used as biomarkers for infectious pleural effusions, especially for CPPE/empy...
Main Authors: | Chia-Yu Yang, Yu-Hsuan Kuo, Min Chen, Chih-Liang Wang, Li-Jane Shih, Yu-Ching Liu, Pei-Chun Hsueh, Yi-Hsuan Lai, Chi-Ming Chu, Chih-Ching Wu, Kuo-An Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-81053-6 |
Similar Items
-
Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema
by: Kuo-An Wu, et al.
Published: (2019-06-01) -
Predictive Value of Pleural Cytology in the Diagnosis of Complicated Parapneumonic Effusions and Empyema Thoracis
by: John Ferguson, et al.
Published: (2020-01-01) -
Derrame pleural parapneumônico e empiema Parapneumonic effusion and empyema
by: Evaldo Marchi, et al.
Published: (2006-08-01) -
Management of parapneumonic effusion and empyema
by: Sarvinder Singh, et al.
Published: (2019-01-01) -
A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.
by: Naoki Tsujimoto, et al.
Published: (2015-01-01)